Modulating telomerase activity in tumor patients by targeting dyskerin binding site for hTR
Medical Hypotheses, 06/15/2012
Katunaric M et al. – The authors suggest a possible therapeutic agent which would disable the interaction of dyskerin and telomerase, but would not completely inhibit telomerase activity.



